Alamar Biosciences, Inc. (California) (ALMR)

34.06 -0.99 (-2.82%) USD  |  NASDAQ  |  Sep 22, 12:43
More

Alamar Biosciences Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for ALMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2026. Start Trial.
Date Value
September 03, 2026 --
August 11, 2026 --
July 16, 2026 --
Date Value
July 15, 2026 --
July 13, 2026 --
May 12, 2026 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
10X Genomics, Inc. Upgrade
Personalis, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Adaptive Biotechnologies Corp. Upgrade
Champions Oncology, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade